Tailor-made agarose-based reactive beads for hemoperfusion and plasma perfusion.

Area of Science:

• Biomaterials Science
• Nephrology
• Cardiovascular Medicine

Background:

• Developing effective extracorporeal blood detoxification methods is crucial for managing toxic ingestions and chronic kidney disease complications.
• Hyperphosphatemia and Paraquat poisoning represent significant clinical challenges requiring efficient removal strategies.
• Familial hypercholesterolemia necessitates advanced therapies for LDL cholesterol reduction.

Purpose of the Study:

• To develop and evaluate composite agarose beads for blood detoxification and cholesterol removal.
• To assess the efficacy of Fuller's Earth and zirconium oxide loaded beads for toxin and phosphate clearance.
• To investigate heparin-bound agarose beads for direct LDL-cholesterol removal via hemoperfusion.

Main Methods:

• Preparation of 1 mm diameter crosslinked agarose beads incorporating Fuller's Earth or zirconium oxide powders.
• Testing bead efficacy in removing Paraquat and inorganic phosphate in relevant models.
• Development and evaluation of heparin-bound crosslinked agarose beads for LDL-cholesterol hemoperfusion.

Main Results:

• Agarose beads with Fuller's Earth demonstrated effective Paraquat removal.
• Zirconium oxide-containing beads successfully reduced inorganic phosphate levels in hyperphosphatemic models.
• Heparin-bound agarose beads exhibited high LDL-cholesterol binding capacity (over 5 mg LDL/mL), suggesting clinical viability.

Conclusions:

• Crosslinked agarose composite beads offer a robust platform for blood detoxification.
• These materials provide mechanical strength, stability, and efficient diffusion for toxin removal.
• Heparin-functionalized agarose beads present a promising, cost-effective alternative to plasmapheresis for hypercholesterolemia treatment.